EA202091288A1 - Импульсное введение вдыхаемого оксида азота (ii) для лечения легочной гипертензии - Google Patents

Импульсное введение вдыхаемого оксида азота (ii) для лечения легочной гипертензии

Info

Publication number
EA202091288A1
EA202091288A1 EA202091288A EA202091288A EA202091288A1 EA 202091288 A1 EA202091288 A1 EA 202091288A1 EA 202091288 A EA202091288 A EA 202091288A EA 202091288 A EA202091288 A EA 202091288A EA 202091288 A1 EA202091288 A1 EA 202091288A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pulmonary hypertension
pulse
treatment
nitrogen oxide
inhaled nitrogen
Prior art date
Application number
EA202091288A
Other languages
English (en)
Inventor
Дебора Куинн
Параг Шах
Мартин Деккер
Original Assignee
Беллерофон Пульс Текнолоджис Ллс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Беллерофон Пульс Текнолоджис Ллс filed Critical Беллерофон Пульс Текнолоджис Ллс
Publication of EA202091288A1 publication Critical patent/EA202091288A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06Respiratory or anaesthetic masks
    • A61M16/0666Nasal cannulas or tubing
    • A61M16/0672Nasal cannula assemblies for oxygen therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/1005Preparation of respiratory gases or vapours with O2 features or with parameter measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/1005Preparation of respiratory gases or vapours with O2 features or with parameter measurement
    • A61M16/101Preparation of respiratory gases or vapours with O2 features or with parameter measurement using an oxygen concentrator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/12Preparation of respiratory gases or vapours by mixing different gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0027Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/0007Special media to be introduced, removed or treated introduced into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0208Oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0266Nitrogen (N)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0266Nitrogen (N)
    • A61M2202/0275Nitric oxide [NO]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/40Respiratory characteristics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/40Respiratory characteristics
    • A61M2230/42Rate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

В настоящей заявке описаны способы лечения легочной гипертензии посредством поддержания частоты дозирования и/или минимизации пропущенных вдохов при импульсном введении вдыхаемого оксида азота (II).
EA202091288A 2017-12-28 2018-12-28 Импульсное введение вдыхаемого оксида азота (ii) для лечения легочной гипертензии EA202091288A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762611331P 2017-12-28 2017-12-28
PCT/US2018/067794 WO2019133777A1 (en) 2017-12-28 2018-12-28 Pulsed administration of inhaled nitric oxide for the treatment of pulmonary hypertension

Publications (1)

Publication Number Publication Date
EA202091288A1 true EA202091288A1 (ru) 2020-11-06

Family

ID=67068179

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202091288A EA202091288A1 (ru) 2017-12-28 2018-12-28 Импульсное введение вдыхаемого оксида азота (ii) для лечения легочной гипертензии

Country Status (15)

Country Link
US (1) US20200384014A1 (ru)
EP (1) EP3731847A4 (ru)
JP (1) JP2021509109A (ru)
KR (1) KR20200127158A (ru)
CN (1) CN111867604A (ru)
AU (1) AU2018397752A1 (ru)
BR (1) BR112020013109A2 (ru)
CA (1) CA3087198A1 (ru)
EA (1) EA202091288A1 (ru)
IL (1) IL275683A (ru)
MX (1) MX2020006740A (ru)
PH (1) PH12020550979A1 (ru)
SG (1) SG11202005975XA (ru)
TW (1) TW201929842A (ru)
WO (1) WO2019133777A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
CN113456966A (zh) 2017-02-27 2021-10-01 第三极股份有限公司 用于移动生成一氧化氮的系统和方法
CN113620263A (zh) 2017-02-27 2021-11-09 第三极股份有限公司 生成一氧化氮的系统和方法
EP3969415A4 (en) 2019-05-15 2023-08-16 Third Pole, Inc. ELECTRODES FOR NITRIC OXIDE GENERATION
JP2022532654A (ja) 2019-05-15 2022-07-15 サード ポール,インコーポレイテッド 一酸化窒素を生成するシステム及び方法
CN115151183A (zh) 2020-01-11 2022-10-04 第三极股份有限公司 具有湿度控制的用于一氧化氮生成的系统和方法
EP4096634A4 (en) * 2020-01-31 2024-03-06 Bellerophon Therapeutics IMPROVING PULMONARY ARTERIAL COMPLIANCE USING INHALED NITRIC OXIDE (INO) TREATMENT
CN116096446A (zh) * 2020-05-29 2023-05-09 背勒丰治疗公司 脉冲递送气态药物的方法
EP4167920A1 (en) 2020-06-18 2023-04-26 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
EP4351723A2 (en) * 2021-06-11 2024-04-17 Acceleron Pharma Inc. Actrii proteins and uses thereof
US11975139B2 (en) 2021-09-23 2024-05-07 Third Pole, Inc. Systems and methods for delivering nitric oxide
WO2023133399A1 (en) * 2022-01-04 2023-07-13 Bellerophon Therapeutics Use of inhaled nitric oxide (ino) for treating patients with pulmonary hypertension associated with sarcoidosis (ph-sarc)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6109260A (en) * 1998-02-18 2000-08-29 Datex-Ohmeda, Inc. Nitric oxide administration device with timed pulse
US8893717B2 (en) * 2005-09-21 2014-11-25 Ino Therapeutics Llc Systems and methods of administering a pharmaceutical gas to a patient
US20120093948A1 (en) * 2009-11-20 2012-04-19 Fine David H Nitric Oxide Treatments
WO2012075420A1 (en) * 2010-12-03 2012-06-07 Geno Llc Nitric oxide treatments
US20130239962A1 (en) * 2012-03-15 2013-09-19 Ino Therapeutics Llc Methods Of Administering High Concentrations Of Nitric Oxide
MX368858B (es) * 2012-03-15 2019-10-18 Mallinckrodt Hospital Products Ip Ltd Metodos para administrar altas concentraciones de oxido nitrico.
US10039781B2 (en) * 2015-03-24 2018-08-07 Ait Therapeutics, Inc. Pulse inhalation of nitric oxide for treating respiratory diseases
BR112018011762A2 (pt) * 2015-12-11 2018-12-04 Vero Biotech LLC método e aparelho para administração de gases inclu-indo óxido nítrico para combater fibrose

Also Published As

Publication number Publication date
KR20200127158A (ko) 2020-11-10
US20200384014A1 (en) 2020-12-10
PH12020550979A1 (en) 2021-03-22
CA3087198A1 (en) 2019-07-04
JP2021509109A (ja) 2021-03-18
AU2018397752A1 (en) 2020-07-02
IL275683A (en) 2020-08-31
WO2019133777A1 (en) 2019-07-04
EP3731847A1 (en) 2020-11-04
EP3731847A4 (en) 2021-08-25
BR112020013109A2 (pt) 2020-11-24
MX2020006740A (es) 2020-11-24
CN111867604A (zh) 2020-10-30
SG11202005975XA (en) 2020-07-29
TW201929842A (zh) 2019-08-01

Similar Documents

Publication Publication Date Title
EA202091288A1 (ru) Импульсное введение вдыхаемого оксида азота (ii) для лечения легочной гипертензии
CY1125214T1 (el) Ενωσεις ν-((ετ)αρυλμεθυλ)-ετεροαρυλ-καρβοξαμιδιων ως αναστολεις καλλικρεϊνης πλασματος
CY1124432T1 (el) Φαρμακευτικες συνθεσεις που αποτελουν ν-(3,5-διμεθοδυφαινυλ)-ν'-(1-μεθυλαιθυλ)-ν-[3-(1--μεθυλ-1η-πυραζολ-4-υλ)κινοοξαλιν-6-υλ]αιθανο-1,2-διαμινη
EA201892510A2 (ru) Комбинированная терапия для лечения рака
EA201790174A1 (ru) Антипролиферативные соединения и способы их применения
UA118453C2 (uk) Спосіб лікування пухлин у пацієнта
EA202091286A1 (ru) Применение вдыхаемого оксида азота (ii) и кислорода для лечения легочной гипертензии
EA201790142A1 (ru) Лечение лейкоза ингибиторами гистондеацетилазы
EA201690456A1 (ru) Способы лечения и предотвращения эндотелиальной дисфункции с применением бардоксолона метила или его аналогов
EA201691155A1 (ru) Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств
PH12020500197A1 (en) Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
EA202191556A1 (ru) Комбинированная терапия радиоиммуноконъюгатами и ингибиторами контрольных точек
MX2021008418A (es) Terapias de farmaco de combinacion de inhibidores de fosfodiesterasa tipo 5 (pde-5) y oxido nitrico inhalado.
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
EA201890878A1 (ru) Способ лечения медуллобластомы с помощью ингибитора ezh2
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
EA201792209A1 (ru) Схема введения пропущенных доз инъекционных сложных эфиров палиперидона длительного действия
MX2018005233A (es) Combinacion de inhibidor de bcl-2 e inhibidor de mek para el tratamiento de cancer.
CY1124751T1 (el) Συνδυαστικες αγωγες οι οποιες περιλαμβανουν χορηγηση 1η-πυραζολο[4,3-b]πυριδινων
EA201792123A1 (ru) Лечение боли
MX2021004755A (es) Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrizacion de heridas y la recuperacion posoperatoria.
DK3615034T3 (da) Rucaparib, talazoparib, veliparib, olaparib og azd 2461 til behandling af forringet hudsårheling
EA201892631A1 (ru) Дигидротестостерон и производные и промоторы дигидротестостерона в лечении рака
EA202090266A1 (ru) Ингибиторы mpo для применения в медицине